Laminate Medical Technologies Ltd.

Laminate Medical Technologies Ltd. focuses on developing innovative medical devices that improve the function of arteriovenous fistulas for hemodialysis patients, enhancing patient care through advanced solutions. Founded in 2012 by Eyal Orion and Tammy Gilon, Laminate Medical Technologies Ltd. is headquartered in Tel Aviv-Yafo, Israel.

The company specializes in medical technology aimed at improving the performance of arteriovenous fistulas. Laminate Medical has successfully raised a total of USD 12. 00 mn, with the latest funding round completed on October 24, 2019, from investors including Asahi Kasei Corporation and Tal Capital Group LLC. The company has conducted 5 deals to date.

Laminate Medical Technologies specializes in developing innovative solutions to enhance arteriovenous fistula (AVF) function for hemodialysis patients. Their flagship product, the VasQ™ External Support, aims to reduce the high primary fistula failure rate, which can be as high as 60%, by providing external support that enhances the likelihood of fistula success without the need for additional procedures. The product has been clinically validated, showing significantly improved functionality in treated fistulas. Laminate Medical serves a diverse client base, including healthcare providers, dialysis centers, and hospitals across the United States and international markets in Europe and Asia-Pacific.

Their commitment to addressing critical challenges in dialysis treatment exemplifies their dedication to improving patient outcomes on a global scale. Laminate Medical Technologies generates revenue primarily through direct sales of its VasQ™ product to healthcare facilities and dialysis providers. The sales structure involves B2B transactions where healthcare institutions procure the device to improve patient care. Given the critical nature of the product, these transactions incorporate contracts or partnerships aimed at ensuring continuous supply and support, aligning with customer needs for regulatory compliance and effective patient treatment options.

Specific pricing plans for VasQ™ are not publicly disclosed; however, the firm engages in structured pricing arrangements that reflect the product's premium positioning in the medical device market. In October 2019, Laminate Medical Technologies Ltd. raised USD 12. 00 mn in funding to support its growth initiatives.

The company plans to expand its product line with new devices aimed at further enhancing AVF performance, with specific launches anticipated in the coming years. Additionally, Laminate Medical is targeting new markets in Europe and Asia-Pacific to increase its reach, aiming for significant expansion by 2023. The recent funding will facilitate these product development efforts and market entry strategies.